FLT3 Mouse Monoclonal Antibody [Clone ID: BV10A4]
CAT#: AM26022PU-N
FLT3 mouse monoclonal antibody, clone BV10A4, Aff - Purified
Need it in bulk or conjugated?
Get a free quote
CNY 3,140.00
货期*
5周
规格
Product images
Specifications
Product Data | |
Clone Name | BV10A4 |
Applications | FC, IP |
Recommend Dilution | Flow cytometry: Tested on cell lines K562 and REH. In this case the recommended concentration is 10 μg/ml per 1 million cells/ml. Immunoprecipitation. |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | BV-173 leukemic cell line |
Specificity | This antibody reacts with CD135 (FLT3, FLK2, STK-1), a 130-160 kDa type III receptor tyrosine kinase that is involved in early steps of hematopoiesis. |
Formulation | PBS, pH 7.4 containing 0,05% sodium azide as stabilizer State: Aff - Purified State: Liquid Ig fraction |
Concentration | lot specific |
Purification | Protein-A affinity chromatography (> 95% by SDS-PAGE) |
Conjugation | Unconjugated |
Storage Condition | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
Gene Name | fms related tyrosine kinase 3 |
Database Link | |
Background | CD135 / FLT3, also known as FLK2 or STK-1 is a receptor tyrosine kinase that plays important roles in hematopoiesis. After binding of Flt3 ligand (FL), CD135 homodimerizes and stimulates proliferation, differentiation and protects the cell from apoptosis. The loss of CD90 and gain of CD135 expression marks the loss of self-renewal in hematopoietic stem cell population. Detectable CD135 expression appears first at low levels on the surface of primitive multilineage progenitor cells and disappears during defined stages of B-cell development, but is upregulated and maintained during maturation of monocytes. CD135 is also expressed on thymocytes, dendritic cell progenitors and on mature dendritic cells, as well as on various malignant hematopoietic cells. |
Synonyms | FL cytokine receptor, STK1 |
Reference Data | |
Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase, Transmembrane |
Protein Pathways | Acute myeloid leukemia, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...